Wird geladen...
MYD88(L265P) Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation
In IgM monoclonal gammopathies MYD88(L265P) is a prognostic and predictive biomarker of therapy response. MYD88(L265P) detection is mainly performed by allele-specific quantitative PCR (ASqPCR), however recently, droplet digital PCR (ddPCR) has been proved to be suitable for MYD88(L265P) screening a...
Gespeichert in:
| Veröffentlicht in: | Diagnostics (Basel) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8146978/ https://ncbi.nlm.nih.gov/pubmed/33926007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11050779 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|